Literature DB >> 30311377

The ClinGen Epilepsy Gene Curation Expert Panel-Bridging the divide between clinical domain knowledge and formal gene curation criteria.

Ingo Helbig1,2, Erin Rooney Riggs3, Carrie-Anne Barry3, Karl Martin Klein4,5, David Dyment6, Courtney Thaxton7, Bekim Sadikovic8, Tristan T Sands9, Jacy L Wagnon10, Khalida Liaquat11, Maria Roberta Cilio12, Ghayda Mirzaa13,14, Kristen Park15, Erika Axeen16, Elizabeth Butler17, Tanya M Bardakjian18, Pasquale Striano19, Annapurna Poduri20, Rebecca K Siegert21, Andrew R Grant21, Katherine L Helbig1, Heather C Mefford22.   

Abstract

The field of epilepsy genetics is advancing rapidly and epilepsy is emerging as a frequent indication for diagnostic genetic testing. Within the larger ClinGen framework, the ClinGen Epilepsy Gene Curation Expert Panel is tasked with connecting two increasingly separate fields: the domain of traditional clinical epileptology, with its own established language and classification criteria, and the rapidly evolving area of diagnostic genetic testing that adheres to formal criteria for gene and variant curation. We identify critical components unique to the epilepsy gene curation effort, including: (a) precise phenotype definitions within existing disease and phenotype ontologies; (b) consideration of when epilepsy should be curated as a distinct disease entity; (c) strategies for gene selection; and (d) emerging rules for evaluating functional models for seizure disorders. Given that de novo variants play a prominent role in many of the epilepsies, sufficient genetic evidence is often awarded early in the curation process. Therefore, the emphasis of gene curation is frequently shifted toward an iterative precuration process to better capture phenotypic associations. We demonstrate that within the spectrum of neurodevelopmental disorders, gene curation for epilepsy-associated genes is feasible and suggest epilepsy-specific conventions, laying the groundwork for a curation process of all major epilepsy-associated genes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ClinGen/Clinical Genome Resource; clinical validity; epilepsy; epileptic encephalopathy; gene-disease association

Mesh:

Year:  2018        PMID: 30311377     DOI: 10.1002/humu.23632

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  14 in total

Review 1.  From Genetic Testing to Precision Medicine in Epilepsy.

Authors:  Pasquale Striano; Berge A Minassian
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

Review 2.  Diagnostic Considerations in the Epilepsies-Testing Strategies, Test Type Advantages, and Limitations.

Authors:  Wei-Liang Chen; Heather C Mefford
Journal:  Neurotherapeutics       Date:  2021-09-16       Impact factor: 6.088

3.  CACNA1H variants are not a cause of monogenic epilepsy.

Authors:  Jeffrey D Calhoun; Alexandra M Huffman; Irena Bellinski; Lisa Kinsley; Elizabeth Bachman; Elizabeth Gerard; Jennifer A Kearney; Gemma L Carvill
Journal:  Hum Mutat       Date:  2020-04-14       Impact factor: 4.878

4.  Modeling seizures in the Human Phenotype Ontology according to contemporary ILAE concepts makes big phenotypic data tractable.

Authors:  David Lewis-Smith; Peter D Galer; Ganna Balagura; Hugh Kearney; Shiva Ganesan; Mahgenn Cosico; Margaret O'Brien; Priya Vaidiswaran; Roland Krause; Colin A Ellis; Rhys H Thomas; Peter N Robinson; Ingo Helbig
Journal:  Epilepsia       Date:  2021-05-05       Impact factor: 6.740

5.  Whole-exome sequencing with targeted analysis and epilepsy after acute symptomatic neonatal seizures.

Authors:  Adam L Numis; Gilberto da Gente; Elliott H Sherr; Hannah C Glass
Journal:  Pediatr Res       Date:  2021-04-12       Impact factor: 3.953

Review 6.  Neuronal Cav3 channelopathies: recent progress and perspectives.

Authors:  Philippe Lory; Sophie Nicole; Arnaud Monteil
Journal:  Pflugers Arch       Date:  2020-07-07       Impact factor: 3.657

7.  Calcium Channel Dysfunction in Epilepsy: Gain of CACNA1E.

Authors:  Gemma L Carvill
Journal:  Epilepsy Curr       Date:  2019-05-07       Impact factor: 7.500

8.  Use of a Dynamic Genetic Testing Approach for Childhood-Onset Epilepsy.

Authors:  Jorune Balciuniene; Elizabeth T DeChene; Gozde Akgumus; Edward J Romasko; Kajia Cao; Holly A Dubbs; Surabhi Mulchandani; Nancy B Spinner; Laura K Conlin; Eric D Marsh; Ethan Goldberg; Ingo Helbig; Mahdi Sarmady; Ahmad Abou Tayoun
Journal:  JAMA Netw Open       Date:  2019-04-05

9.  Curated disease-causing genes for bleeding, thrombotic, and platelet disorders: Communication from the SSC of the ISTH.

Authors:  Karyn Megy; Kate Downes; Ilenia Simeoni; Loredana Bury; Joannella Morales; Rutendo Mapeta; Daniel B Bellissimo; Paul F Bray; Anne C Goodeve; Paolo Gresele; Michele Lambert; Pieter Reitsma; Willem H Ouwehand; Kathleen Freson
Journal:  J Thromb Haemost       Date:  2019-06-09       Impact factor: 5.824

10.  Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions.

Authors:  Bernard S Chang; Vaishnav Krishnan; Chris G Dulla; Nathalie Jette; Eric D Marsh; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-22       Impact factor: 7.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.